CAS: 1448232-80-1

Naquotinib is a unique compound that has a wide range of applications in various fields. It is made from cellulose and copolymers, making it highly versatile and adaptable. Naquotinib can be used as an electrode material due to its excellent conductivity and stability. It also exhibits remarkable properties as an inhibitor, particularly against tyrosinase, which is involved in the synthesis of melanin. This makes it a potential ingredient in skincare products for its skin lightening and brightening effects. In addition, Naquotinib has been studied for its potential use in the field of research chemicals. Its ability to interact with phenylthiourea and acetylcholine has attracted attention from researchers exploring new avenues in neuroscience and pharmacology. Furthermore, Naquotinib shows promise as a component in the development of polymers with enhanced mechanical properties. When incorporated into polymers, it improves their strength and durability, making them suitable for various industrial applications. Overall, Naquotin

Naquotinib (ASP8273) (ASP8273) is an orally available, mutant-selective and irreversible EGFR inhibitor; (IC50s: 8-33 nM and 230 nM toward EGFR mutants and EGFR

(R)-5-((1-Acryloylpyrrolidin-3-Yl)Oxy)-6-Ethyl-3-((4-(4-(4-Methylpiperazin-1-Yl)Piperidin-1-Yl)Phenyl)Amino)Pyrazine-2-Carboxamide

Applications Naquotinib is an epidermal growth factor receptor (EGFR) inhibitor. Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package References Wang, S., et al.: J Hematol Oncol. 9, 34 (2016); Liao, B. C., et al.: J Biomed Sci. 23, 86 (2016)